MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeuticsCyprumed will be eligible to receive up to $493…Read More
You might also be interested in reading Europe’s hopeless negotiations with Donald Trump were a brutal wake-up call, says MAGGIE PAGANO.
